Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Goodacre
Simon Goodacre, Harlow GB
| Patent application number | Description | Published |
|---|---|---|
| 20110118230 | DIAZACARBAZOLES AND METHODS OF USE - The invention relates to 1,7-diazacarbazole compounds of Formula (I), (I-a) and (I-b) which are useful as kinase inhibitors, more specifically useful as checkpoint kinase 1 (chk1) inhibitors, thus useful as cancer therapeutics. The invention also relates to compositions, more specifically pharmaceutical compositions comprising these compounds and methods of using the same to treat various forms of cancer and hyperproliferative disorders, as well as methods of using the compounds for in vitro, in situ, and in vivo diagnosis or treatment of mammalian cells, or associated pathological conditions. | 05-19-2011 |
| 20110124654 | DIAZACARBAZOLES AND METHODS OF USE - The invention relates to 1,5-diazacarbazole compounds of Formula (I), (I-a), (I-b), (I-c), (I-d), (I-e), (I-f), (I-g) and (I-h) which are useful as kinase inhibitors, more specifically useful as checkpoint kinase 1 (chk1) inhibitors, thus useful as cancer therapeutics. The invention also relates to compositions, more specifically pharmaceutical compositions comprising these compounds and methods of using the same to treat various forms of cancer and hyperproliferative disorders, as well as methods of using the compounds for in vitro, in situ, and in vivo diagnosis or treatment of mammalian cells, or associated pathological conditions. | 05-26-2011 |
Simon Charles Goodacre, Flex Meadow GB
| Patent application number | Description | Published |
|---|---|---|
| 20100317643 | JANUS KINASE INHIBITOR COMPOUNDS AND METHODS - The invention provides compounds of Formula I, stereoisomers or pharmaceutically acceptable salts thereof, wherein A, B, D, R | 12-16-2010 |
Simon Charles Goodacre, Harlow GB
| Patent application number | Description | Published |
|---|---|---|
| 20080242655 | AZA-INDOLYL COMPOUNDS AND METHODS OF USE - The invention relates to azaindolyl compounds of Formula I with anti-cancer and/or anti-inflammatory activity and more specifically to azaindolyl compounds which inhibit MEK kinase activity. The invention provides compositions and methods useful for inhibiting abnormal cell growth or treating a hyperproliferative disorder, or treating an inflammatory disease in a mammal. The invention also relates to methods of using the compounds for in vitro, in situ, and in vivo diagnosis or treatment of mammalian cells, or associated pathological conditions. | 10-02-2008 |
Timothy A. Goodacre, Lisle, IL US
| Patent application number | Description | Published |
|---|---|---|
| 20080310422 | DATA CENTER VIRTUAL LOCAL AREA NETWORK SYSTEM AND METHOD - A method, system and service for a data center computer network. A core network switches data using a first protocol layer. A first access switch is in electrical communication with the core network. The first access switch communicates the data to the core network using the first protocol layer. A second redundant access switch forms a first access switch pair with the first access switch. The second access switch is in electrical communication with the core network and communicates the data using the first protocol layer. The second access switch is in electrical communication with first access switch and communicates with the first access switch using a second protocol layer. The second protocol layer is at lower OSI level than the first protocol layer. The first access switch and the second access switch are configured to form a first VLAN. A first edge device is in electrical communication with the first access switch and the second access switch. The first edge device is part of the first VLAN. | 12-18-2008 |